Total genomic alteration as measured by SNP-array-based molecular karyotyping is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

Metaphase cytogenetics (MC) has a major role in the risk stratification of patients with myelodysplastic syndromes (MDSs) and can affect the choice of therapies. Azacitidine (AZA) has changed the outcome of patients with MDS or acute myeloid leukemia (AML) unfit for intensive chemotherapy. Identific...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cluzeau, T, Moreilhon, C, Mounier, N, Karsenti, J-M, Gastaud, L, Garnier, G, Re, D, Montagne, N, Gutnecht, J, Auberger, P, Fuzibet, J G, Cassuto, J-P, Raynaud, S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3880435/
https://ncbi.nlm.nih.gov/pubmed/24185502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2013.52
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados